IDT Stock Overview
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally.
IDT Australia Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.088|
|52 Week High||AU$0.52|
|52 Week Low||AU$0.087|
|1 Month Change||-12.00%|
|3 Month Change||-26.67%|
|1 Year Change||-82.40%|
|3 Year Change||-32.31%|
|5 Year Change||14.29%|
|Change since IPO||-43.67%|
Recent News & Updates
IDT Australia Limited's (ASX:IDT) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/E RatioMar 04
Here's Why Shareholders Will Not Be Complaining About IDT Australia Limited's (ASX:IDT) CEO Pay PacketNov 09
IDT Australia's (ASX:IDT) Promising Earnings May Rest On Soft FoundationsAug 31
Is IDT Australia's (ASX:IDT) 280% Share Price Increase Well Justified?Mar 20
IDT Australia (ASX:IDT) Is In A Good Position To Deliver On Growth PlansJan 13
Does IDT Australia's (ASX:IDT) CEO Salary Compare Well With The Performance Of The Company?Dec 09
|IDT||AU Pharmaceuticals||AU Market|
Return vs Industry: IDT underperformed the Australian Pharmaceuticals industry which returned -30.7% over the past year.
Return vs Market: IDT underperformed the Australian Market which returned -4.7% over the past year.
|IDT Average Weekly Movement||8.2%|
|Pharmaceuticals Industry Average Movement||10.6%|
|Market Average Movement||8.9%|
|10% most volatile stocks in AU Market||15.8%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: IDT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: IDT's weekly volatility (8%) has been stable over the past year.
About the Company
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms.
IDT Australia Limited Fundamentals Summary
|IDT fundamental statistics|
Is IDT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IDT income statement (TTM)|
|Cost of Revenue||AU$5.02m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.0048|
|Net Profit Margin||-9.56%|
How did IDT perform over the long term?See historical performance and comparison